B-Raf IN 7 is a potent B-Raf inhibitor with an IC50 of 110.23 nM; it exhibits strong antitumor activity against colon cancer (HCT-116), breast cancer (MCF-7), hepatocellular carcinoma (HepG-2), human cervical cancer (HeLa), and human prostate cancer (PC-3) cells, with IC50 values of 7.50, 9.87, 10.57, 11.63, and 12.83 µM, respectively.